Riskpilot← Back to searchSign inGet full accessRecipharm AB
ABActiveOrg 5564988425Vasagatan 10Activities of head offices · NACE 7010Est. 199444 employees
Revenue 2024
SEK 603,6M
-14% vs 2023
EBITDA margin
-47.2%
+7% vs 2023
Equity ratio
38.6%
Financial strength
Net profit 2024
SEK 5,6B
+163% vs 2023
| Revenue | SEK 603,6M | -14% |
| EBITDA | SEK -284,7M | +7% |
| Net profit | SEK 5,6B | +163% |
| Total assets | SEK 20,3B | -12% |
| Equity | SEK 7,8B | -15% |
| Employees | 44 | — |
Legal name
Recipharm AB
Org number
5564988425
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
25 november 1994
Share capital
SEK 50 558 000
Employees
44 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Behar, Gregory Erwin
Company purpose
Föremålet för bolagets verksamhet är att bedriva miljömedveten utveckling, tillverkning och försäljning av läkemedel, naturläkemedel, naturmedel, kosttillskott, medicinska hjälpmedel, relaterade tjänster och därmed förenlig verksamhet.
Address
Vasagatan 10
Phone
+4686025200
Email
emmanuel.grand@recipharm.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 4 678 300 | 5 331 900 | 6 374 000 | 183 300 | 207 000 | 247 874 | 595 436 | 705 541 | 603 602 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −50 300 | 749 300 | 524 400 | 986 000 | −109 000 | −84 000 | −248 631 | −176 402 | −306 495 | −284 688 |
| Depreciation & amort. | −5 600 | −365 000 | −533 100 | −581 000 | −31 000 | −31 000 | −32 429 | −30 888 | −31 404 | −22 898 |
| EBIT | −55 900 | 384 300 | −8 700 | 405 000 | −140 000 | −115 000 | −281 060 | −207 290 | −337 899 | −307 586 |
| Net financials | 191 400 | −132 700 | −141 600 | −237 000 | −231 300 | −494 000 | 359 869 | 186 203 | −8 472 200 | 5 624 398 |
| Profit before tax | 135 500 | 296 900 | −121 400 | 229 000 | 44 300 | −429 000 | 119 636 | 79 223 | −8 648 211 | 5 540 342 |
| Tax | −0 | −100 300 | −38 600 | −69 000 | 1 000 | −0 | 219 | 171 825 | −171 802 | 11 631 |
| Net profit | 135 500 | 196 600 | −160 000 | 160 000 | 45 300 | −429 000 | 119 855 | 251 048 | −8 820 013 | 5 551 973 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 717 600 | 9 830 400 | 11 731 000 | 12 716 000 | 9 910 900 | 16 662 000 | 17 368 210 | 29 509 387 | 22 947 164 | 20 283 987 |
| Equity | 2 040 800 | 4 786 900 | 4 548 500 | 5 337 000 | 3 915 700 | 5 985 000 | 7 066 773 | 17 984 299 | 9 163 215 | 7 831 597 |
| Long-term debt | 1 585 500 | 2 564 300 | 5 327 300 | 5 347 000 | 4 861 200 | 8 895 000 | 8 602 136 | 9 401 381 | 9 373 765 | 9 974 501 |
| Short-term debt | 90 300 | 1 052 100 | 1 252 200 | 1 408 000 | 1 128 800 | 1 776 000 | 1 663 025 | 2 114 465 | 4 399 448 | 2 453 913 |
| Total debt | 1 675 800 | 3 616 400 | 6 579 500 | 6 755 000 | 5 990 000 | 10 671 000 | 10 265 161 | 11 515 846 | 13 773 213 | 12 428 414 |
EBITDA margin
-47.2%
This company
15.8%
Market median
-399% vs market
20152024
Equity ratio
38.6%
This company
38.2%
Market median
+1% vs market
20152024
Return on equity
70.9%
This company
18.4%
Market median
+285% vs market
20152024
Net profit margin
919.8%
This company
8.1%
Market median
+11256% vs market
20152024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20152024
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GB Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
JH Chief Auditor | Chief Auditor | 2024 | — | — |
TB Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
HU Authorized Recipient of Service | Authorized Recipient of Service | 2026 | — | — |
DR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
JR Chief Auditor | Chief Auditor | 2020 | — | — |
VS Authorized Recipient of Service | Authorized Recipient of Service | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Roar Bidco AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Roar Holdco ABRoar Bidco AB
Recipharm AB (this company)Recipharm Italia SpaRecipharm Participation BvRecipharm (Americas) IncRecipharm Holdings LtdGenibet Biopharmaceuticals S.aLio Immobiliare SrlLusomedicamenta SaRM 2959 Vermögenverwaltungs GmbhRecipharm Americas IncRecipharm Participation SasRecipharm Pessac SasRECIPHARM ITALIA SPARECIPHARM AMERICAS INCLUSOMEDICAMENTA SARM 2959 VERMÖGENVERWALTUNGS GMBHRECIPHARM PARTICIPATION SASRECIPHARM PARTICIPATION BVRecipharm Leganés SluRecipharm Parets S.L.uRecipharm Leganés S.L.uRECIPHARM LEGANÉS S.L.ULIO IMMOBILIARE SRLRECIPHARM HOLDINGS LTDGENIBET BIOPHARMACEUTICALS S.ABoard members of Recipharm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gregory Behar | Chief Executive Officer | 0 companies |
| Johan Henrik Jonzén | Chief Auditor | 0 companies |
| Thomas Bengt Eldered | Chief Executive Officer | 0 companies |
| Ashwini Mohan Kakkar | Chief Executive Officer | 0 companies |
| Hanna Ulrika Edberg | Authorized Recipient of Service | 0 companies |
| Daniela Roxin | Chief Executive Officer | 0 companies |
| Jennifer Rock Baley | Chief Auditor | 0 companies |
| Valur Sveinbjörnsson | Authorized Recipient of Service | 0 companies |
| Marie Helena Levander | Board of Directors | 0 companies |
| Joaquin Mascaro Beneyto | Board of Directors | 0 companies |
| M C Dicander Alexandersson | Board of Directors | 0 companies |
| Per Anders Gustav Carlberg | Board of Directors | 0 companies |
| Henrik Oscar Giver | Board of Directors | 0 companies |
| Carlos Jorge Santos von Bonhorst Silva | Board of Directors | 0 companies |
| Bengt Olle Christenson | Board of Directors | 0 companies |
| Markus Funk | Board of Directors | 0 companies |
| Thomas Ebeling | Board of Directors | 0 companies |
| Christophe Lamacq | Board of Directors | 0 companies |
| Mark Burgess Keatly | Board of Directors | 0 companies |
| Clare Jane Bousfield | Board of Directors | 0 companies |
| Luc Albert Raymond Burgard | Board of Directors | 0 companies |
| Matthias Martin Wittkowski | Board of Directors | 0 companies |
| Erika Karin Elisabeth Henriksson | Board of Directors | 0 companies |
| Richard Johann Karl Ridinger | Chairman | 0 companies |
| Lars Rickard Backsell | Chairman | 0 companies |
| Steven Mark Klosk | Board of Directors | 0 companies |
| Emmanuel Nicolas Grand | Board of Directors | 0 companies |
| Eva Ulrika Saers | Board of Directors | 0 companies |